Double-blind trials with ethamsylate, batroxobin or tranexamic acid on blood loss after adenotonsillectomy.
D000233:Adenoidectomy / Q000009:adverse effects*; D012103:Batroxobin / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004341:Drug Evaluation; D004979:Ethamsylate / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D010919:Placebos; D011183:Postoperative Complications / Q000188:drug therapy*; D014068:Tonsillectomy / Q000009:adverse effects*; D014148:Tranexamic Acid / Q000627:therapeutic use*
D001557:Benzenesulfonates; D003509:Cyclohexanecarboxylic Acids; D010919:Placebos; D004979:Ethamsylate; D014148:Tranexamic Acid; D010447:Peptide Hydrolases; D012103:Batroxobin